Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Kamenge University Hospital, Burundi University, Burundi | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Longitudinal study in Burundi to evaluate the effectiveness, the acceptability and safety of thermal ablation in the treatment of cervical neoplasia.
The study population consisted of women with an abnormal VIA test or an abnormal colposcopy examination. A total of 86 women with lesions eligible to ablative treatment were counselled and treated by thermal ablation. Informed consent was signed by each participant. Just after treatment, they were inquired about the level of pain during the procedure, and their level of satisfaction with the treatment. They were followed-up at 6 weeks for any complication and re-assessed by VIA and colposcopy at 12 months for any persistent or recurrent lesion and for any adverse event.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intervention Arm | Experimental | Treatment of cervical neoplasia by thermal ablation |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Treatment of cervical neoplasia by thermal ablation | Device | Women screened for cervical cancer by visual inspection with diluted acetic acid (VIA) presenting lesions eligible for ablative treatment were treated by thermal ablation. The treatment consisted in applying the probe on the lesion for 45 seconds at 100 degrees Celsius, with one to up to five applications depending on the lesion size. Following treatment, women were inquired about the pain level during the procedure, their satisfaction level of the procedure and whether they would recommend this treatment to their relatives. Women had a follow-up visit at 6 weeks to assess any complication of the procedure. Women were rescreened at 12 months, to evaluate the cure rate and any long-term adverse events. |
| Measure | Description | Time Frame |
|---|---|---|
| Cure rate based on VIA and colposcopy assessment | Effectiveness is measured by the cure rate after 1 year based on VIA and colposcopy assessment. | 1 year |
| Acceptability of thermal ablation | Measured by existence of minor/moderate adverse events during the follow-up. | 6 weeks |
| Acceptability of thermal ablation | Measured by the satisfaction level using a nine-level Likert scale (from 1. Very unsatisfied to 9. very satisfied). | At day 1 |
| Safety of thermal ablation | Measured by existence of severe adverse events during the follow-up period. | 1 year |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Sylvestre Bazikamwe, MD | Kamenge University Hospital, Burundi University, Bujumbura, Burundi | Principal Investigator |
| Catherine Sauvaget, MD, PhD | International Agency for Research on Cancer | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Kamenge University Hospital | Bujumbura | 2210 | Burundi |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 35567576 | Result | Sauvaget C, Bazikamwe S, Lucas E, Ndayikengurukiye A, Harerimana S, Barango P. Evaluation of effectiveness, acceptability and safety of thermal ablation in the treatment of cervical neoplasia in Burundi. Int J Cancer. 2022 Oct 1;151(7):1120-1126. doi: 10.1002/ijc.34117. Epub 2022 Jun 3. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|